EGFR Resisters and LUNGevity Foundation Partner on Lung Cancer Research Award
WASHINGTON, Feb. 19, 2021 /PRNewswire/ — Patient group EGFR Resisters and LUNGevity Foundation today announced the 2021 recipients of the first EGFR Resisters/LUNGevity Lung Cancer Research Award. This award program, driven by EGFR Resisters—a grassroots patient-led group that has 2,500+…
Comments Off on EGFR Resisters and LUNGevity Foundation Partner on Lung Cancer Research Award